Frontlight ResearchEarly access
What researchers published on Mantle cell lymphoma
2,638 papers, newest first.
Showing 20 of 349
Meta-analysisClinical, economic, and quality-of-life outcomes of brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma and B-cell acute lymphoblastic leukemia: A systematic literature review and meta-analysis.Journal of managed care & specialty pharmacy
In plain wordsRead moreRead the paper on PubMedReview[Advances in single cell omics applications in mantle cell lymphoma].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Meta-analysisComparative Efficacy of BTK Inhibitors in Treatment-Naïve and Relapsed/Refractory Mantle Cell Lymphoma: A Systematic Review and Meta-Analysis.Journal of cellular and molecular medicine
In plain wordsRead moreRead the paper on PubMedReviewHigh time for risk-adapted treatment in mantle cell lymphoma.The Lancet. Haematology
ReviewBTK Inhibitors for the Treatment of Mantle Cell Lymphoma-Current Status and Perspectives.Cancers
Systematic reviewCAR T-cell vs bispecific antibodies in relapsed/refractory mantle cell lymphoma: a systematic review and meta-analysis.Frontiers in oncology
In plain wordsRead moreRead the paper on PubMedReviewRefining risk stratification for mantle cell lymphoma: integrating novel combination treatments and personalized approaches.Expert review of hematology
Review[Recent advances and future perspectives in the treatment of mantle cell lymphoma].[Rinsho ketsueki] The Japanese journal of clinical hematology
ReviewEvolution of mantle cell lymphoma therapy: advancing frontline precision.Trends in cancer
ReviewFirst-Line Bruton's Tyrosine Kinase Inhibitor-Based Regimens for Mantle Cell Lymphoma.Current oncology (Toronto, Ont.)
ReviewMantle Cell Lymphoma in Geriatric Patients: Biologic Risk Stratification, Fitness-Adapted Strategies, and Unmet Needs.European journal of haematology
Systematic reviewAn unanchored matching-adjusted indirect comparison of the efficacy of zanubrutinib versus ibrutinib for the treatment of relapsed/refractory mantle-cell lymphoma.Journal of medical economics
In plain wordsRead moreRead the paper on PubMedReviewAdvances in targeted and cellular therapies for relapsed/refractory mantle cell lymphoma: immunotherapeutic strategies and challenges.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
ReviewThe preclinical discovery and development of acalabrutinib for the treatment of mantle cell lymphoma.Expert opinion on drug discovery
ReviewIn mantle cell lymphoma, whether 18 F-FDG PET/CT or flow cytometry provide superior diagnostic performance compared to biopsy in the determination of bone marrow involvement and enhance prognostic predictive value.Annals of hematology
ReviewSOHO State of the Art Updates and Next Questions | Accessing BTK Inhibitors and Other Novel Therapies for Mantle Cell Lymphoma: Are We All Invited to the Party?Clinical lymphoma, myeloma & leukemia
Systematic reviewAssociation Between Progression-Free Survival and Overall Survival in Mantle Cell Lymphoma: A Trial-level Surrogate Endpoint Analysis.Clinical lymphoma, myeloma & leukemia
In plain wordsRead moreRead the paper on PubMedReviewModern Management of Mantle Cell Lymphoma.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
ReviewExtracellular Vesicles in B-Cell Non-Hodgkin Lymphomas: Pathogenesis, Therapeutic Implications, and Biomarker Potential.Biomedicines
ReviewSonrotoclax: First Approval.Drugs